These prompted us to study the involvement of ARL4C, as a KRAS downstream molecule, in aggressiveness of pancreatic cancer, and IQ-domain GTPase-activation protein 1 (IQGAP1) was identified as a binding protein of ARL4C. The gene discussed is ARL4C; the disease is pancreatic neoplasm.